Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles
Teeth Whitening Products

FDA Seeks Public Input On Transparency
The U.S. Food and Drug Administration will host a daylong meeting on June 24, 2009. During this meeting, the FDA will seek recommendations on how to make information on FDA activities and decision-making useful, understandable, and more accessible to the public. The meeting is scheduled for 8 a.m. to 5 p.m. EDT at the National Transportation Safety Board Conference Center, 429 L"Enfant Plaza, S.W., Washington, D.C., 20594.
generic viagra online
Better Monitoring, Better Prognosis In Liver Disease
The latest research in liver disease being presented at Digestive Disease Week® 2009 (DDW®) has important implications for tracking disease development in patients and for current and future transplant recipients. Researchers are making great strides in diagnosing and treating liver disease.
News of the day
Merck KGaA Considers Appealing CHMP Opinion On Erbitux Treatment For Non-Small Cell Lung Cancer
The Committee for Medicinal Products for Human Use (CHMP), the scientific committee of the European Medicines Agency (EMEA), has adopted a negative opinion for the use of Erbitux® (cetuximab) in combination with platinum-based chemotherapy for the treatment of patients with epidermal growth factor receptor (EGFR)-expressing, advanced or metastatic non-small cell lung cancer (NSCLC). Merck KGaA is evaluating potential appeal options requesting that the CHMP re-examine data demonstrating clinical relevant benefits to patients.
Public Health

Scottsdale Healthcare Is West's Only Clinical Research Site For "Dream Team" Pancreatic Cancer Research Studies

Scottsdale Healthcare, through its strategic alliance with the Translational Genomics Research Institute (TGen), is one of three clinical research sites in the United States that will participate in a three-year investigation into new approaches to treating pancreatic cancer, the fourth leading cause of cancer death in the U.S. The clinical trials will be designed to deprive pancreatic tumors of crucial nutrients, thereby cutting off the fuel supply. Understanding the cell"s fuel supply will help scientists develop more individualized treatments with fewer side effects. Scottsdale Healthcare became a primary clinical research site for TGen in 2005, a strategic alliance resulting in creation of TCRS, which is housed in the Virginia G. Piper Cancer Center at Scottsdale Healthcare. Cancer patients from across the U.S. and other countries regularly travel to Scottsdale Healthcare to participate in groundbreaking clinical trials. The Scottsdale Healthcare-TGen alliance facilitates bench-to-bedside application of new research discoveries in patients with advanced cancer. Other clinical research sites in the study are the University of Pennsylvania in Philadelphia and John Hopkins University in Baltimore. Scottsdale Healthcare


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009